Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Moderna Inc reported $3.44B in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 290.9M 176.05M
Acorda Therapeutics ACOR:US USD 30.26M 7.28M
Agios Pharmaceuticals AGIO:US USD 104.14M 35.12M
Alnylam Pharmaceuticals ALNY:US USD 672.24M 194.15M
Amgen AMGN:US USD 31.56B 22.26B
Arrowhead Research ARWR:US USD 134.96M 67.29M
Biogen BIIB:US USD 2.9B 521.1M
BioMarin Pharmaceutical BMRN:US USD 580.07M 144.46M
Bluebird Bio BLUE:US USD 239.04M 126.04M
Esperion Therapeutics ESPR:US USD 144.91M 20.14M
Gilead Sciences GILD:US USD 7.2B 430M
GlaxoSmithKline GSK:LN GBP 2.89B 833M
Incyte Corp INCY:US USD 2.82B 130.37M
Intercept Pharmaceuticals ICPT:US USD 61.4M 10.89M
Ionis Pharmaceuticals IONS:US USD 309.03M 32.56M
Mirati Therapeutics MRTX:US USD 232.96M 50.74M
Puma Biotechnology PBYI:US USD 61.39M 14.81M
Regeneron Pharmaceuticals REGN:US USD 3.92B 810.4M
Sangamo BioSciences SGMO:US USD 78.24M 22.2M
Sarepta Therapeutics SRPT:US USD 871.67M 95.11M
Seattle Genetics SGEN:US USD 335.85M 15.91M
Ultragenyx Pharmaceutical RARE:US USD 85.77M 47.18M
United Therapeutics UTHR:US USD 1.16B 202.3M
Vertex Pharmaceuticals VRTX:US USD 9.29B 1.21B